Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Maurel, Joan"" wg kryterium: Autor


Tytuł:
Metabolic interventions to enhance immunotherapy and targeted therapy efficacy in advanced colorectal cancer.
Autorzy:
Oliveres H; Medical Oncology Department, Hospital Clinic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, Barcelona, Spain.
Cascante M; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Biochemistry and Molecular Biomedicine and Institute of Biomedicine (IBUB), Universitat de Barcelona, Barcelona, Spain. Electronic address: .
Maurel J; Medical Oncology Department, Hospital Clinic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło:
Current opinion in chemical biology [Curr Opin Chem Biol] 2023 Dec; Vol. 77, pp. 102401. Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Humans ; Immunotherapy ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
Autorzy:
Okuno, KeisukeAff1, Aff2
Kandimalla, Raju
Mendiola, Marta
Balaguer, Francesc
Bujanda, Luis
Fernandez-Martos, Carlos
Aparicio, Jorge
Feliu, Jaime
Tokunaga, Masanori
Kinugasa, Yusuke
Maurel, Joan
Goel, AjayAff1, Aff3, Aff10, IDs12943022016992_cor12
Pokaż więcej
Źródło:
Molecular Cancer. 22(1)
Czasopismo naukowe
Tytuł:
The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas.
Autorzy:
Sánchez-Tilló E; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Department of Oncology and Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Group of Gastrointestinal and Pancreatic Oncology, Department of Liver, Digestive System and Metabolism, IDIBAPS, Barcelona, Spain.; Biomedical Research Network in Gastrointestinal and Liver Diseases (CIBEREHD), Carlos III National Health Institute (ISCIII), Barcelona, Spain.
Pedrosa L; Group of Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, and Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
Vila I; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Department of Oncology and Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Chen Y; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Department of Oncology and Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Győrffy B; Cancer Biomarker Research Group, Research Centre for Natural Sciences (TKK), and Department of Bioinformatics and 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
Sánchez-Moral L; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Department of Oncology and Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Siles L; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Department of Oncology and Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Lozano JJ; Bioinformatics Platform, CIBEREHD, ISCIII, Barcelona, Spain.
Esteve-Codina A; National Centre for Genomic Analysis (CNAG) Center for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Department of Medicine and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Darling DS; Department of Oral Immunology, and Center for Genetics and Molecular Medicine, University of Louisville, Louisville, Kentucky, USA.
Cuatrecasas M; Biomedical Research Network in Gastrointestinal and Liver Diseases (CIBEREHD), Carlos III National Health Institute (ISCIII), Barcelona, Spain.; Group of Molecular Pathology of Inflammatory Conditions and Solid Tumours, Department of Oncology and Hematology, IDIBAPS, Barcelona, Spain.; Department of Pathology, Hospital Clínic and University of Barcelona School of Medicine, Barcelona, Spain.
Castells A; Group of Gastrointestinal and Pancreatic Oncology, Department of Liver, Digestive System and Metabolism, IDIBAPS, Barcelona, Spain.; Biomedical Research Network in Gastrointestinal and Liver Diseases (CIBEREHD), Carlos III National Health Institute (ISCIII), Barcelona, Spain.; Department of Gastroenterology, Hospital Clinic and University of Barcelona School of Medicine, Barcelona, Spain.
Maurel J; Biomedical Research Network in Gastrointestinal and Liver Diseases (CIBEREHD), Carlos III National Health Institute (ISCIII), Barcelona, Spain.; Group of Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, and Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
Postigo A; Group of Gene Regulation in Stem Cells, Cell Plasticity, Differentiation, and Cancer, Department of Oncology and Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biomedical Research Network in Gastrointestinal and Liver Diseases (CIBEREHD), Carlos III National Health Institute (ISCIII), Barcelona, Spain.; Molecular Targets Program, Department of Medicine, J.G. Brown Cancer Center, Louisville, Kentucky, USA.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
Pokaż więcej
Źródło:
JCI insight [JCI Insight] 2023 Oct 23; Vol. 8 (20). Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma*
Colorectal Neoplasms*/pathology
Proto-Oncogene Proteins B-raf*/genetics
Proto-Oncogene Proteins B-raf*/metabolism
Zinc Finger E-box-Binding Homeobox 1*/genetics
Zinc Finger E-box-Binding Homeobox 1*/metabolism
Animals ; Humans ; Mice ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł:
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022).
Autorzy:
Fernández Montes A; Medical Oncology Department, Complexo Hospitalario Universitario, Ourense (CHUO), C/ Ramón Puga, 56, 32005, Ourense, Spain. .
Alonso V; Medical Oncology Department, Hospital Universitario Miguel Servet, Saragossa, Spain.
Aranda E; Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
Élez E; Medical Oncology Department, Hospital Universitario Vall D'Hebron, Barcelona, Spain.
García Alfonso P; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Grávalos C; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Maurel J; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.
Vera R; Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain.
Vidal R; Medical Oncology Department, Complejo Asistencial Universitario, Salamanca, Spain.
Aparicio J; Medical Oncology Department, Hospital Universitari I Politècnic la Fe, Valencia, Spain.
Pokaż więcej
Źródło:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Sep; Vol. 25 (9), pp. 2718-2731. Date of Electronic Publication: 2023 May 03.
Typ publikacji:
Journal Article
MeSH Terms:
Colonic Neoplasms*
Rectal Neoplasms*
Humans ; Disease Management ; Patient Preference ; Spain
Czasopismo naukowe
Tytuł:
Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
Autorzy:
Trilla-Fuertes L; Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.
Gámez-Pozo A; Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.
Nogué M; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital de Granollers, Barcelona, Spain.
Busquier I; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain.
Arias F; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Radiotherapy Oncology Service, Complejo Hospitalario de Navarra, Navarra, Spain.
López-Campos F; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Radiotherapy Oncology Service, Hospital Ramón y Cajal, Madrid, Spain.
Fernández-Montes A; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.
Ruiz A; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
Velázquez C; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain.
Martín-Bravo C; Medical Oncology Service, Hospital Costa del Sol, Málaga, Spain.
Pérez-Ruiz E; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain.
Asensio E; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital General Universitario de Elche, Elche, Spain.
Hernández-Yagüe X; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Instituto Catalán de Oncología-Girona, Girona, Spain.
Rodrigues A; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca, Spain.
Ghanem I; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Universitario La Paz, Madrid, Spain.
López-Vacas R; Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.
Hafez A; Biotechvana SL, Parque Científico de Madrid, Madrid, Spain.
Arias P; Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain.
Dapía I; Pharmacogenetics Lab, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Autonomous University of Madrid, Madrid, Spain.
Solís M; Bioinformatics Unit, Institute of Medical and Molecular Genetics-INGEMM, La Paz University Hospital-IdiPAZ, Madrid, Spain.
Dittmann A; Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland.
Ramos R; Genomics Unit, Parque Científico de Madrid, Madrid, Spain.
Llorens C; Biotechvana SL, Parque Científico de Madrid, Madrid, Spain.
Maurel J; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.
Campos-Barros Á; Institute of Medical and Molecular Genetics, IdiPAZ, Hospital Universitario La Paz/CIBERER Unit 753, ISCIII, Madrid, Spain.
Fresno Vara JÁ; Molecular Oncology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain.
Feliu J; Spanish Multidisciplinary Group of Digestive Cancer, Barcelona, Spain.; Medical Oncology Service, Hospital Universitario La Paz, Madrid, Spain.; Biomedical Research Networking Center on Oncology-CIBERONC, ISCIII, Madrid, Spain.; Cátedra UAM-Amgen, Universidad Autónoma de Madrid, Madrid, Spain.
Pokaż więcej
Źródło:
Cancer [Cancer] 2023 Aug 15; Vol. 129 (16), pp. 2581-2592. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anus Neoplasms*/genetics
Anus Neoplasms*/therapy
Anus Neoplasms*/pathology
Carcinoma, Squamous Cell*/therapy
Carcinoma, Squamous Cell*/drug therapy
Female ; Humans ; Male ; Middle Aged ; Biomarkers ; Cytochrome P-450 CYP2D6/genetics ; DNA Copy Number Variations ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study.
Autorzy:
Español-Rego M; Immunology Department, Hospital Clínic, Barcelona, Spain.
Fernández-Martos C; Medical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain.
Elez E; Medical Oncology Department, Vall d'Hebrón Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
Foguet C; Department of Biochemistry and Molecular Medicine, Universitat de Barcelona, Barcelona, Spain.
Pedrosa L; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, C. Villarroel, 170. 08036, Barcelona, Spain.
Rodríguez N; Medical Oncology Department, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Ruiz-Casado A; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Pineda E; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, C. Villarroel, 170. 08036, Barcelona, Spain.
Cid J; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, IDIBAPS, Hospital Clínic, Barcelona, Spain.
Cabezón R; Immunology Department, Hospital Clínic, Barcelona, Spain.
Oliveres H; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, C. Villarroel, 170. 08036, Barcelona, Spain.
Lozano M; Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, IDIBAPS, Hospital Clínic, Barcelona, Spain.
Ginés A; Endoscopic Unit, Gastrointestinal Service, Hospital Clínic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.; Networked Center for Hepatic and Digestive Diseases (CIBER-EHD), Instituto Nacional de La Salud Carlos III, Madrid, Spain.
García-Criado A; Radiology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Ayuso JR; Radiology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Pagés M; Radiology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Cuatrecasas M; Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain.; Networked Center for Hepatic and Digestive Diseases (CIBER-EHD), Instituto Nacional de La Salud Carlos III, Madrid, Spain.
Torres F; Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
Thomson T; Barcelona Institute for Molecular Biology, National Science Council (IBMB-CSIC), Barcelona, Spain.; Networked Center for Hepatic and Digestive Diseases (CIBER-EHD), Instituto Nacional de La Salud Carlos III, Madrid, Spain.; Universidad Peruana Cayetano Heredia, Lima, Peru.
Cascante M; Department of Biochemistry and Molecular Medicine, Universitat de Barcelona, Barcelona, Spain.; Networked Center for Hepatic and Digestive Diseases (CIBER-EHD), Instituto Nacional de La Salud Carlos III, Madrid, Spain.
Benítez-Ribas D; Immunology Department, Hospital Clínic, Barcelona, Spain. .
Maurel J; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, C. Villarroel, 170. 08036, Barcelona, Spain. .; Networked Center for Hepatic and Digestive Diseases (CIBER-EHD), Instituto Nacional de La Salud Carlos III, Madrid, Spain. .
Pokaż więcej
Źródło:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Apr; Vol. 72 (4), pp. 827-840. Date of Electronic Publication: 2022 Sep 09.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Cancer Vaccines*/therapeutic use
Colorectal Neoplasms*
Colonic Neoplasms*/drug therapy
Rectal Neoplasms*/drug therapy
Humans ; DNA Mismatch Repair ; Dendritic Cells ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Cytology Smears: An Enhanced Alternative Method for Colorectal Cancer pN Stage—A Multicentre Study.
Autorzy:
Diaz-Mercedes, Sherley (AUTHOR)
Archilla, Ivan (AUTHOR)
Lahoz, Sara (AUTHOR)
Rodrigo-Calvo, Maria Teresa (AUTHOR)
Lopez-Prades, Sandra (AUTHOR)
Tarragona, Jordi (AUTHOR)
Landolfi, Stefania (AUTHOR)
Concha, Angel (AUTHOR)
Machado, Isidro (AUTHOR)
Maurel, Joan (AUTHOR)
Chic, Nuria (AUTHOR)
Castells, Antoni (AUTHOR)
Balaguer, Francesc (AUTHOR)
Camps, Jordi (AUTHOR)
Cuatrecasas, Miriam (AUTHOR)
Pokaż więcej
Źródło:
Cancers. 12/15/2022, Vol. 14 Issue 24, p6072. 15p.
Czasopismo naukowe
Tytuł:
A metastasis-associated microRNA-based liquid biopsy signature for risk-stratification in colorectal cancer: a multicenter cohort study.
Autorzy:
Matsuyama T; Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.; Department of Gastrointestinal Surgery, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Toiyama Y; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Graduate School of Medicine, Mie University, Mie, Japan.
Ishikawa T; Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Okugawa Y; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Graduate School of Medicine, Mie University, Mie, Japan.
Yasuno M; Department of Gastrointestinal Surgery, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Maurel J; Translational Genomics and Targeted Therapeutics in Solid Tumors Group Medical Oncology, Hospital Clinic of Barcelona, CIBERehd, IDIBAPS, Barcelona, Spain.
Kinugasa Y; Department of Gastrointestinal Surgery, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Uetake H; Department of Specialized Surgery, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Goel A; Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.; Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Monrovia, California, USA.; City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2022 Dec; Vol. 12 (12), pp. e998.
Typ publikacji:
Multicenter Study; Letter; Research Support, N.I.H., Extramural
MeSH Terms:
MicroRNAs*/genetics
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Humans ; Liquid Biopsy ; Cohort Studies
Raport
Tytuł:
Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53 –Mutated Metastatic Colorectal Cancer.
Autorzy:
Lahoz, Sara (AUTHOR)
Rodríguez, Adela (AUTHOR)
Fernández, Laia (AUTHOR)
Gorría, Teresa (AUTHOR)
Moreno, Reinaldo (AUTHOR)
Esposito, Francis (AUTHOR)
Oliveres, Helena (AUTHOR)
Albiol, Santiago (AUTHOR)
Saurí, Tamara (AUTHOR)
Pesantez, David (AUTHOR)
Riu, Gisela (AUTHOR)
Cuatrecasas, Miriam (AUTHOR)
Jares, Pedro (AUTHOR)
Pedrosa, Leire (AUTHOR)
Pineda, Estela (AUTHOR)
Postigo, Antonio (AUTHOR)
Castells, Antoni (AUTHOR)
Prat, Aleix (AUTHOR)
Maurel, Joan (AUTHOR)
Camps, Jordi (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Dec2022, Vol. 14 Issue 23, p5921. 19p.
Czasopismo naukowe
Tytuł:
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01).
Autorzy:
Aparicio J; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Avda. Abril Martorell 106, 46026, Valencia, Spain. .
Virgili Manrique AC; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Capdevila J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; IOB-Teknon, Barcelona, Spain.
Muñoz Boza F; Medical Oncology Department, Hospital Universitari Sant Joan de Reus, Reus, Spain.
Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, Medical Oncology Department, Hospital Clínic de Barcelona, C/ Villaroel, 170, 08036, Barcelona, Spain.
Richart P; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Avda. Abril Martorell 106, 46026, Valencia, Spain.
Oliveres H; Translational Genomics and Targeted Therapies in Solid Tumors, Medical Oncology Department, Hospital Clínic de Barcelona, C/ Villaroel, 170, 08036, Barcelona, Spain.
Páez D; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Hernando J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Serrano S; Medical Oncology Department, Hospital Universitari Sant Joan de Reus, Reus, Spain.
Vera R; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
Hernandez-Yagüe X; Medical Oncology Department, ICO, Girona, Girona, Spain.
Gallego RÁ; Medical Oncology Department, Hospital Madrid Norte San Chinarro-Centro Integral Oncologico Clara Campal, Madrid, Spain.
Riesco-Martinez MC; Medical Oncology Department, Hospital Universitario, 12 Octubre, Madrid, Spain.
García de Albeniz X; RTI Health Solutions, Barcelona, Spain.
Maurel J; Translational Genomics and Targeted Therapies in Solid Tumors, Medical Oncology Department, Hospital Clínic de Barcelona, C/ Villaroel, 170, 08036, Barcelona, Spain. .
Pokaż więcej
Źródło:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Nov; Vol. 24 (11), pp. 2155-2165. Date of Electronic Publication: 2022 Jun 27.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms:
Circulating Tumor DNA*/genetics
Colonic Neoplasms*/etiology
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Rectal Neoplasms*
Antibodies, Monoclonal/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Camptothecin/therapeutic use ; Disease Progression ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/therapeutic use ; Panitumumab/therapeutic use ; Proto-Oncogene Proteins B-raf/genetics
Czasopismo naukowe
Tytuł:
A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes.
Autorzy:
Pedrosa L; Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Foguet C; Department of Biochemistry and Molecular Biomedicine and Institute of Biomedicine (IBUB), Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Oliveres H; Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Archilla I; Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
de Herreros MG; Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Rodríguez A; Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Postigo A; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Group of Transcriptional Regulation of Gene Expression, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Institución Catalana de Investigación y Estudios Avanzados (ICREA) and Department of Biomedicine, Universitat de Barcelona, Barcelona, Spain.
Benítez-Ribas D; Immunology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Camps J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Gastrointestinal Oncology Department, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Cuatrecasas M; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Castells A; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Gastrointestinal Oncology Department, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Prat A; Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Thomson TM; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Department of Cell Biology, Molecular Biology Institute, National Research Council (IBMB-CSIC), Barcelona, Spain.; Universidad Peruana Cayetano Heredia, Lima, Peru.
Maurel J; Medical Oncology Department, Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.; Gastrointestinal Oncology Department, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Cascante M; Department of Biochemistry and Molecular Biomedicine and Institute of Biomedicine (IBUB), Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Sep 02; Vol. 13, pp. 926304. Date of Electronic Publication: 2022 Sep 02 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glutamine*
Neoplasms*
Carbon ; Glucose ; Hexosamines ; Humans ; Hypoglycemic Agents ; Lactates ; Lipids ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
A novel gene signature unveils three distinct immunemetabolic rewiring patterns conserved across diverse tumor types and associated with outcomes.
Autorzy:
Pedrosa, Leire
Foguet, Carles
Oliveres, Helena
Archilla, Iván
de Herreros, Marta Garcıá
Rodríguez, Adela
Postigo, Antonio
Benítez-Ribas, Daniel
Camps, Jordi
Cuatrecasas, Miriam
Castells, Antoni
Prat, Aleix
Thomson, Timothy M.
Maurel, Joan
Cascante, Marta
Pokaż więcej
Temat:
IMMUNE checkpoint inhibitors
PENTOSE phosphate pathway
ESSENTIAL amino acids
WARBURG Effect (Oncology)
Źródło:
Frontiers in Immunology; 9/2/2022, Vol. 13, p1-14, 14p
Czasopismo naukowe
Tytuł:
Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy.
Autorzy:
Albayrak M; Neurology Department, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.; Department of Medicine, Facultat de Medicina I Ciències de La Salut-Campus Clinic, Universitat de Barcelona, C/Casanova, 143, 08036, Barcelona, Catalonia, Spain.
Figueras C; Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.
Seguí E; Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.
Campolo M; Neurology Department, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.
Gabarrón E; Neurology Department, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.
Moreno R; Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.
Maurel J; Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain.; Institut d'Investigació Biomedica Agustí Pi Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.; Department of Medicine, Facultat de Medicina I Ciències de La Salut-Campus Clinic, Universitat de Barcelona, C/Casanova, 143, 08036, Barcelona, Catalonia, Spain.
Casanova-Molla J; Neurology Department, Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain. .; Institut d'Investigació Biomedica Agustí Pi Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. .; Department of Medicine, Facultat de Medicina I Ciències de La Salut-Campus Clinic, Universitat de Barcelona, C/Casanova, 143, 08036, Barcelona, Catalonia, Spain. .
Pokaż więcej
Źródło:
Journal of neurology [J Neurol] 2022 Aug; Vol. 269 (8), pp. 4174-4184. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
GAP-43 Protein*/metabolism
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/pathology
Humans ; Neoplasms/drug therapy ; Oxaliplatin/adverse effects ; Prognosis ; Skin/innervation ; Skin/pathology
Czasopismo naukowe
Tytuł:
Impact of microscopic incomplete resection for colorectal liver metastases on surgical margin recurrence: R1-Contact vs R1 < 1 mm margin width.
Autorzy:
Ausania F; Department of General and Digestive Surgery, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Landi F; Department of General and Digestive Surgery, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Martínez-Pérez A; Faculty of Health Sciences, Valencian International University, Valencia, Spain.
Sandomenico R; Department of General and Digestive Surgery, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Cuatrecasas M; Department of Pathology, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Pages M; Department of Radiology, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Maurel J; Department of Medical Oncology, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Garcia R; Department of General and Digestive Surgery, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Fuster J; Department of General and Digestive Surgery, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Garcia-Valdecasas JC; Department of General and Digestive Surgery, Hospital Clínic, Universidad de Barcelona, IDIBAPS, Barcelona, Spain.
Pokaż więcej
Źródło:
Journal of hepato-biliary-pancreatic sciences [J Hepatobiliary Pancreat Sci] 2022 Apr; Vol. 29 (4), pp. 449-459. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/pathology
Liver Neoplasms*
Hepatectomy ; Humans ; Margins of Excision ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Impact of microscopic incomplete resection for colorectal liver metastases on surgical margin recurrence: R1‐Contact vs R1 < 1 mm margin width.
Autorzy:
Ausania, Fabio
Landi, Filippo
Martínez‐Pérez, Aleix
Sandomenico, Raffaele
Cuatrecasas, Miriam
Pages, Mario
Maurel, Joan
Garcia, Rocio
Fuster, Josep
Garcia‐Valdecasas, Juan Carlos
Pokaż więcej
Źródło:
Journal of Hepato -- Biliary -- Pancreatic Sciences; Apr2022, Vol. 29 Issue 4, p449-459, 11p
Czasopismo naukowe
Tytuł:
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab
Autorzy:
Trilla-Fuertes, Lucía
Gámez-Pozo, AngeloAff1, Aff2
Maurel, Joan
Garcia-Carbonero, Rocio
Capdevila, Jaume
G-Pastrián, LauraAff6, Aff7
Mendiola, MartaAff7, Aff8
Peña, Cristina
López-Vacas, Rocío
Cuatrecasas, Miriam
García-Alfonso, Pilar
Ramos-Ruiz, Ricardo
Llorens, Carlos
Ghanem, Ismael
Conill, Carles
Heredia-Soto, VictoriaAff8, Aff15
Campos-Barros, Ángel
Fresno Vara, Juan ÁngelAff2, Aff8
Feliu, JaimeAff8, Aff13, Aff17
Pokaż więcej
Źródło:
Scientific Reports. 11(1)
Czasopismo naukowe
Tytuł:
Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients.
Autorzy:
Oliveres H; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
Pesántez D; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.
Maurel J; Translational Genomics and Targeted Therapeutics in Solid Tumors Group, Medical Oncology Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, 08036 Barcelona, Spain.; Gastrointestinal and Pancreatic Oncology Group, Hospital Clínic, IDIBAPS, CIBERehd, University of Barcelona, 08036 Barcelona, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 May 09; Vol. 22 (9). Date of Electronic Publication: 2021 May 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Colorectal Neoplasms/*pathology
Colorectal Neoplasms/*therapy
Biomarkers, Tumor ; Colorectal Neoplasms/etiology ; Colorectal Neoplasms/metabolism ; Drug Resistance, Neoplasm/drug effects ; Epithelial-Mesenchymal Transition/drug effects ; Humans ; Liquid Biopsy ; Molecular Targeted Therapy ; Neoplasm Metastasis ; Neoplasm Staging ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Protein Processing, Post-Translational ; Receptor, IGF Type 1/metabolism ; Signal Transduction/drug effects ; Treatment Outcome ; Tumor Microenvironment/drug effects ; ras Proteins/metabolism
Czasopismo naukowe
Tytuł:
Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?
Autorzy:
Rodriguez, Adela (AUTHOR)
Esposito, Francis (AUTHOR)
Oliveres, Helena (AUTHOR)
Torres, Ferran (AUTHOR)
Maurel, Joan (AUTHOR)
Brown, Joshua D. (AUTHOR)
Pokaż więcej
Źródło:
Journal of Clinical Medicine. Feb2021, Vol. 10 Issue 4, p746-746. 1p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies